Biofrontera, Inc. (BFRI)
0.8857
+0.03
(+3.00%)
USD |
NASDAQ |
Feb 20, 16:00
0.8797
-0.01
(-0.68%)
Pre-Market: 20:00
Biofrontera EPS Diluted (Quarterly) : -0.617 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -0.0412 |
| BioStem Technologies, Inc. | 0.0328 |
| Iovance Biotherapeutics, Inc. | -0.2507 |
| Protokinetix, Inc. | -0.0002 |
| GB Sciences, Inc. | -0.0002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.649M |
| Revenue (Quarterly) | 6.988M |
| Total Expenses (Quarterly) | 13.64M |
| Enterprise Value | 11.79M |
| Gross Profit Margin (Quarterly) | 70.44% |
| Profit Margin (Quarterly) | -95.15% |
| Earnings Yield | -205.2% |
| Normalized Earnings Yield | -212.40 |